EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Novel Clinical Insights From a Swedish RFC1 Spectrum Disorder Cohort

Victor Alm iD, Linda Säll, Kristin Samuelsson, Rayomand Press, Snjolaug Arnardottir, Anna Lindstrand, Valter Niemelä iD, Lilia Terinte, Frida Nordin, Per Svenningsson, Daniel Nilsson, Luca Verrecchia and 1 more

European Journal of Neurology · 2026

DOI: 10.1111/ene.70488 ↗

At a glance

Journal article in European Journal of Neurology, 2026. Written by Victor Alm and 12 co-authors. Institution: Department of Neurology, Karolinska University Hospital, Stockholm, Sweden. Major MEDLINE topics: Replication Protein C, Cerebellar Ataxia, Vestibular Diseases, Bilateral Vestibulopathy. Cited 5 times so far (Crossref); 23 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Region Stockholm.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Biallelic pentanucleotide expansions in RFC1 cause cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS), and a growing spectrum of presentations. We aimed to clinically characterize a cohort of patients from Sweden with biallelic expansions in RFC1 .

Methods

We retrospectively enrolled patients with homozygous expansions in RFC1 from a tertiary center in Sweden, evaluating clinical and genetic data. Assessments included nerve conduction studies (NCS, n = 27), electromyography ( n = 7), quantitative sensory testing ( n = 18), brain MRI ( n = 27), and vestibular/eye motor tests ( n = 18–21).

Results

Of the 30 patients enrolled, 28 were ethnic Swedish; 17/30 from smaller regions, including eight (27%) from Norrbotten. Twenty‐two patients met the CANVAS criteria. Mean age of onset was 52 ± 12 years (range 20–70), and disease duration was 14 ± 12 years. Symptoms matched the CANVAS acronym with multisystemic features in 83%, including dysautonomia (77%), dyskinesia (36%), and bradykinesia (17%). Phenotypes overlapped with MSA‐C ( n = 2) and mitochondrial ataxias ( n = 1). Notably, one symptomatic patient lacked neuropathy on NCS. Annual disease progression was slow (0.3 by spinocerebellar degeneration functional score, 1.2 by SARA). At vestibular testing, 47% showed a preserved caloric response and pathologic angular VOR with a nonsignificant trend among younger patients and milder ataxia; otolith function was largely preserved.

Discussion

Our findings expand the RFC1 spectrum, suggesting a founder effect in Sweden and extensive subclinical involvement. RFC1‐spectrum disorder should also be considered in patients with cerebellar and vestibular dysfunction but lacking neuropathy. A discordant VOR pattern may represent an incipient sign of RFC1‐ spectrum disorder; interestingly, otolith pathways seem to be generally spared.

Subjects

MeSH terms (MEDLINE)

Replication Protein CCerebellar AtaxiaVestibular DiseasesBilateral VestibulopathyHumansFemaleSwedenMaleMiddle AgedAdultAgedRetrospective StudiesYoung AdultCohort StudiesNerve Conduction StudiesDNA Repeat Expansion

Author keywords

RFC1CANVASGanglionopathyNeuropathyVEMPbilateral vestibulopathycerebellar ataxiavHITvestibular areflexiavestibulo‐ocular reflex

Substances

Replication Protein CRFC1 protein, human

Authors and institutions

  • Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Department of Clinical Genetics and Genomics, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Department of Medical Sciences, Neurology, Uppsala University, Uppsala, Sweden.
  • Department of Neurology, Sunderby Hospital, Sweden.

ORCID profiles: Victor Alm, Valter Niemelä

Funding

  • Region Stockholm

Cite

APA

Alm, V., Säll, L., Samuelsson, K., Press, R., Arnardottir, S., Lindstrand, A., Niemelä, V., Terinte, L., Nordin, F., Svenningsson, P., Nilsson, D., Verrecchia, L., & Paucar, M. (2026). Novel Clinical Insights From a Swedish RFC1 Spectrum Disorder Cohort. European Journal of Neurology. https://doi.org/10.1111/ene.70488

Vancouver

Alm V, Säll L, Samuelsson K, Press R, Arnardottir S, Lindstrand A, et al. Novel Clinical Insights From a Swedish RFC1 Spectrum Disorder Cohort. European Journal of Neurology. 2026. doi:10.1111/ene.70488

BibTeX
@article{Alm2026,
  author = {Alm, Victor and Säll, Linda and Samuelsson, Kristin and Press, Rayomand and Arnardottir, Snjolaug and Lindstrand, Anna and Niemelä, Valter and Terinte, Lilia and Nordin, Frida and Svenningsson, Per and Nilsson, Daniel and Verrecchia, Luca and Paucar, Martin},
  title = {Novel Clinical Insights From a Swedish RFC1 Spectrum Disorder Cohort},
  journal = {European Journal of Neurology},
  year = {2026},
  doi = {10.1111/ene.70488}
}
Start for free →